Literature DB >> 27293829

Safety and feasibility of prolonged bronchoscopy involving diagnosis of lung cancer, systematic nodal staging, and fiducial marker placement in a high-risk population.

Harman Kular1, Lakshmi Mudambi1, Donald R Lazarus1, Lorraine Cornwell1, Angela Zhu1, Roberto F Casal1.   

Abstract

BACKGROUND: Stereotactic body radiation therapy (SBRT) is considered the standard treatment for medically inoperable early stage lung cancer. Bronchoscopy has shown to be effective in obtaining diagnosis of peripheral lung tumors, staging the mediastinum (with endobronchial ultrasound- EBUS-), and placing fiducial markers (FMs). However, the combination of these 3 procedures in a single bronchoscopy has not been studied. The aim of this study is to describe safety and feasibility of performing diagnosis, systematic nodal staging, and placement of FMs in a single bronchoscopic procedure.
METHODS: Retrospective review of patients who underwent bronchoscopy with diagnosis of peripheral lung cancer, EBUS for nodal staging, and FM placement in a single procedure at Michael E. DeBakey VA Medical Center between January 2011 and July 2015.
RESULTS: Twenty-one patients met our criteria, one having 2 synchronous tumors. 95% of patients had an ASA score of at least 3. Twenty-two tumors were diagnosed with a size of 2.72±1.06 cm. Distance from pleura was 1.33±1.42 cm. Median duration of bronchoscopy was 96 minutes (range, 75 to 136 minutes). Guided-bronchoscopy provided diagnosis of lung cancer in all cases. Fluoroscopy and RP-EBUS were utilized in 21 patients, "hybrid" scope in 14, and electromagnetic navigational bronchoscopy in 3. A total of 100 lymph nodes (LN) were sampled with EBUS-TBNA, with 95% of the patients having at least 4 LN sampled. A total of 71 FM were placed for 22 tumors. All markers were retained and allowed for successful SBRT. There were no pneumothoraces and no major complications.
CONCLUSIONS: Although it results in lengthy procedures, a single bronchoscopy obtaining diagnosis of peripheral lung nodules, systematic nodal staging, and FM placement can be safely performed in high-risk patients. Our "all-in-one" strategy could potentially expedite treatment, decrease complications, and reduce costs. Further prospective studies are needed to corroborate our findings.

Entities:  

Keywords:  Lung cancer; bronchoscopy; interventional techniques

Year:  2016        PMID: 27293829      PMCID: PMC4886017          DOI: 10.21037/jtd.2016.04.06

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  17 in total

1.  Clinical outcome of fiducial-less CyberKnife radiosurgery for stage I non-small cell lung cancer.

Authors:  In-Hye Jung; Si Yeol Song; Jinhong Jung; Byungchul Cho; Jungwon Kwak; Hyoung Uk Je; Wonsik Choi; Nuri Hyun Jung; Su Ssan Kim; Eun Kyung Choi
Journal:  Radiat Oncol J       Date:  2015-06-30

2.  Trainee impact on procedural complications: an analysis of 967 consecutive flexible bronchoscopy procedures in an interventional pulmonology practice.

Authors:  David R Stather; Paul MacEachern; Alex Chee; Elaine Dumoulin; Alain Tremblay
Journal:  Respiration       Date:  2013-03-12       Impact factor: 3.580

3.  Electromagnetic Navigational Bronchoscopy: A Safe and Effective Method for Fiducial Marker Placement in Lung Cancer Patients.

Authors:  William D Bolton; John Richey; Sharon Ben-Or; Allyson L Hale; Joseph A Ewing; James E Stephenson
Journal:  Am Surg       Date:  2015-07       Impact factor: 0.688

4.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Authors:  Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth
Journal:  Lancet Oncol       Date:  2015-05-13       Impact factor: 41.316

5.  Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: clinical outcome.

Authors:  Noëlle C van der Voort van Zyp; Jean-Briac Prévost; Mischa S Hoogeman; John Praag; Bronno van der Holt; Peter C Levendag; Robertus J van Klaveren; Peter Pattynama; Joost J Nuyttens
Journal:  Radiother Oncol       Date:  2009-03-16       Impact factor: 6.280

6.  Electromagnetic navigation bronchoscopy-guided fiducial placement for robotic stereotactic radiosurgery of lung tumors: a feasibility study.

Authors:  Devanand Anantham; David Feller-Kopman; Lakshmi N Shanmugham; Stuart M Berman; Malcolm M DeCamp; Sidhu P Gangadharan; Ralf Eberhardt; Felix Herth; Armin Ernst
Journal:  Chest       Date:  2007-07-23       Impact factor: 9.410

7.  Electromagnetic navigational bronchoscopy-guided fiducial markers for lung stereotactic body radiation therapy: analysis of safety, feasibility, and interfraction stability.

Authors:  Nima Nabavizadeh; Junan Zhang; David A Elliott; James A Tanyi; Charles R Thomas; Martin Fuss; Mark Deffebach
Journal:  J Bronchology Interv Pulmonol       Date:  2014-04

8.  Fiducial marker placement via conventional or electromagnetic navigation bronchoscopy (ENB): an interdisciplinary approach to the curative management of lung cancer.

Authors:  Lars Hagmeyer; Christina Priegnitz; Martin Kocher; Burkhart Schilcher; Wilfried Budach; Marcel Treml; Sven Stieglitz; Winfried Randerath
Journal:  Clin Respir J       Date:  2014-11-03       Impact factor: 2.570

9.  Fiducial marker placement using endobronchial ultrasound and navigational bronchoscopy for stereotactic radiosurgery: an alternative strategy.

Authors:  Daniel P Harley; William S Krimsky; Saiyad Sarkar; David Highfield; Cengis Aygun; Burak Gurses
Journal:  Ann Thorac Surg       Date:  2010-02       Impact factor: 4.330

10.  Radical stereotactic radiosurgery with real-time tumor motion tracking in the treatment of small peripheral lung tumors.

Authors:  Brian T Collins; Kelly Erickson; Cristina A Reichner; Sean P Collins; Gregory J Gagnon; Sonja Dieterich; Don A McRae; Ying Zhang; Shadi Yousefi; Elliot Levy; Thomas Chang; Carlos Jamis-Dow; Filip Banovac; Eric D Anderson
Journal:  Radiat Oncol       Date:  2007-10-22       Impact factor: 3.481

View more
  3 in total

Review 1.  Fiducial marker placement for stereotactic body radiation therapy via convex probe endobronchial ultrasound: a case series and review of literature.

Authors:  Benjamin J Seides; John P Egan; Kim D French; Kevin L Kovitz; Neeraj R Desai
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

2.  Metastasis-associated protein 2 promotes the metastasis of non-small cell lung carcinoma by regulating the ERK/AKT and VEGF signaling pathways.

Authors:  Bin Zhang; Feng Tao; Hao Zhang
Journal:  Mol Med Rep       Date:  2018-02-01       Impact factor: 2.952

3.  Diagnostic value of rapid on-site evaluation in interventional pulmonology: A protocol for systematic review and meta analysis.

Authors:  Xiangwen Weng; Lijia Zhi; Xing An; Meixin Xu; Hua Zhang; Kunlan Long; Peiyang Gao
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.